Mogi M - Search Results

1

Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression.

Okumura M, Iwai M, Ide A, Mogi M, Ito M, Horiuchi M. Okumura M, et al. Among authors: mogi m. Hypertension. 2005 Sep;46(3):577-83. doi: 10.1161/01.HYP.0000178564.14464.80. Epub 2005 Aug 15. Hypertension. 2005. PMID: 16103268

2

Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells.

Li JM, Iwai M, Cui TX, Min LJ, Tsuda M, Iwanami J, Suzuki J, Mogi M, Horiuchi M. Li JM, et al. Among authors: mogi m. Mol Pharmacol. 2005 May;67(5):1666-73. doi: 10.1124/mol.104.008144. Epub 2005 Feb 4. Mol Pharmacol. 2005. PMID: 15695623

3

Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.

Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M. Tsuda M, et al. Among authors: mogi m. Hypertension. 2005 Apr;45(4):545-51. doi: 10.1161/01.HYP.0000157409.88971.fc. Epub 2005 Feb 21. Hypertension. 2005. PMID: 15723967

4

Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Suzuki J, Iwai M, Li Z, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M, Horiuchi M. Suzuki J, et al. Among authors: mogi m. J Hypertens. 2005 Jul;23(7):1383-9. doi: 10.1097/01.hjh.0000173521.91104.5f. J Hypertens. 2005. PMID: 15942461

5

Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.

Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M. Min LJ, et al. Among authors: mogi m. Circ Res. 2005 Sep 2;97(5):434-42. doi: 10.1161/01.RES.0000180753.63183.95. Epub 2005 Aug 4. Circ Res. 2005. PMID: 16081869

6

Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.

Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M. Iwai M, et al. Among authors: mogi m. Circulation. 2005 Sep 13;112(11):1636-43. doi: 10.1161/CIRCULATIONAHA.104.525550. Epub 2005 Sep 6. Circulation. 2005. PMID: 16145000

7

Nifedipine inhibited angiotensin II-induced monocyte chemoattractant protein 1 expression: involvement of inhibitor of nuclear factor kappa B kinase and nuclear factor kappa B-inducing kinase.

Wu L, Iwai M, Li Z, Li JM, Mogi M, Horiuchi M. Wu L, et al. Among authors: mogi m. J Hypertens. 2006 Jan;24(1):123-30. doi: 10.1097/01.hjh.0000198031.30095.d1. J Hypertens. 2006. PMID: 16331110

8

The role of tumor necrosis factor-alpha in inducing insulin resistance in the renin-angiotensin system.

Iwai M, Mogi M, Horiuchi M. Iwai M, et al. Among authors: mogi m. Hypertens Res. 2005 Sep;28(9):701-2. doi: 10.1291/hypres.28.701. Hypertens Res. 2005. PMID: 16419641 No abstract available.

9

Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation.

Suzuki J, Iwai M, Mogi M, Oshita A, Yoshii T, Higaki J, Horiuchi M. Suzuki J, et al. Among authors: mogi m. Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):917-21. doi: 10.1161/01.ATV.0000204635.75748.0f. Epub 2006 Jan 19. Arterioscler Thromb Vasc Biol. 2006. PMID: 16424347

10

New paradigm for brain protection after stroke.

Mogi M, Iwai M, Horiuchi M. Mogi M, et al. Hypertension. 2006 Apr;47(4):642-3. doi: 10.1161/01.HYP.0000208621.87845.67. Epub 2006 Feb 27. Hypertension. 2006. PMID: 16505198 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters